A Study to Evaluate RMC-035 in Subjects Undergoing Cardiac Surgery

Clinical trial NCT04829916 · COMPLETED

Trial details

NCT number: NCT04829916
Sponsor: Guard Therapeutics AB
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Kidney Injury (AKI)

Start date: 2021-03-16
Primary completion: 2021-07-15
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.